$BMSN Company News






10-Q: BIO-MATRIX SCIENTIFIC GROUP, INC.
4:01 p.m. Aug. 13, 2014
- Edgar Online - (EDG = 10Q, 10K)




10-Q: BIO-MATRIX SCIENTIFIC GROUP, INC.
9:40 a.m. May 13, 2014
- Edgar Online - (EDG = 10Q, 10K)





Regen Bio provides an update on IND

1:52 p.m. May 12, 2014
- Seeking Alpha




10-Q: BIO-MATRIX SCIENTIFIC GROUP, INC.
7:10 p.m. Feb. 6, 2014
- Edgar Online - (EDG = 10Q, 10K)




10-K: BIO-MATRIX SCIENTIFIC GROUP, INC.
3:51 p.m. Jan. 7, 2014
- Edgar Online - (EDG = 10Q, 10K)




10-Q: BIO-MATRIX SCIENTIFIC GROUP, INC.
12:52 p.m. Aug. 14, 2013
- Edgar Online - (EDG = 10Q, 10K)




10-K/A: BIO-MATRIX SCIENTIFIC GROUP, INC.
2:00 p.m. July 31, 2013
- Edgar Online - (EDG = 10Q, 10K)




10-K/A: BIO-MATRIX SCIENTIFIC GROUP, INC.
11:02 a.m. June 21, 2013
- Edgar Online - (EDG = 10Q, 10K)




10-Q/A: BIO-MATRIX SCIENTIFIC GROUP, INC.
10:49 a.m. June 21, 2013
- Edgar Online - (EDG = 10Q, 10K)




10-Q/A: BIO-MATRIX SCIENTIFIC GROUP, INC.
10:42 a.m. June 21, 2013
- Edgar Online - (EDG = 10Q, 10K)




10-Q: BIO-MATRIX SCIENTIFIC GROUP, INC.
1:07 p.m. May 17, 2013
- Edgar Online - (EDG = 10Q, 10K)









Regen BioPharma Provides Update on dCellVax Breast Cancer
Immunotherapy
10:01 a.m. Aug. 1, 2014
- Marketwire




Bio-Matrix Scientific Group Inc. Subsidiary Regen BioPharma Inc.
Collaborates on Research Paper Analyzing the Use of Gene Silencing in
Heart Transplants
10:01 a.m. June 11, 2014
- Marketwire




Bio-Matrix Scientific Group, Inc. Sees 37% Increase In Share Price
10:52 a.m. May 13, 2014
- ACCESSWIRE




Regen BioPharma, a Majority Owned Subsidiary of Bio-Matrix Scientific
Group, Provides Update on HemaXellerate I(TM) IND for Treatment of
Drug Resistant Aplastic Anemia
12:32 p.m. May 12, 2014
- Marketwire




Bio-Matrix Scientific Group Inc. Announces Dividend Record Date to
Receive Shares in Its Subsidiary Regen BioPharma, Inc.
3:54 p.m. March 6, 2014
- Marketwire




Regen BioPharma Announces HemaXellerate I(TM) Efficacy Data in Animal
Model of Aplastic Anemia
10:35 a.m. Dec. 11, 2013
- Marketwire




Bio-Matrix Scientific Group's Regen BioPharma Retains Cook General
Biotechnology for Contract Manufacturing of HemaXellerate I
11:36 a.m. Oct. 31, 2013
- Marketwire




New In-Depth Stock Reports on BMSN, CERP, NAMG and NVIV
1:03 a.m. Oct. 25, 2013
- ACCESSWIRE




Bio-Matrix Scientific Group Inc. Announces 20 Million Share Regen
BioPharma Dividend to Be Paid to Shareholders
3:12 p.m. Oct. 9, 2013
- Marketwire




Bio-Matrix Scientific Group's Subsidiary Regen BioPharma Enters Into
Preclinical Trials Agreement for HemaXellerate I Covering Aplastic
Anemia
8:01 a.m. Sept. 26, 2013
- Marketwire




Bio-Matrix Scientific Group's Subsidiary, Regen BioPharma Announces
dCellVax Breast Cancer Immunotherapeutic Product
8:31 a.m. Sept. 25, 2013
- Marketwire




Bio-Matrix Scientific Group Recruits RNA Interference Pioneer Dr.
David Suhy to Regen BioPharma Inc.'s Scientific Advisor Board
10:07 a.m. Sept. 17, 2013
- Marketwire




Bio-Matrix Scientific Group Discusses Regen BioPharma's Cancer
Immunotherapy Program
1:49 p.m. Aug. 16, 2013
- Marketwire




Regen BioPharma Inc. Licenses Cancer Gene Silencing Technology From
Benitec BioPharma
9:48 a.m. Aug. 8, 2013
- Marketwire




Bio-Matrix Scientific Group Provides Update on Its Regen BioPharma's
HemaXellerate I(TM) Clinical Program
2:37 p.m. July 31, 2013
- Marketwire




Bio-Matrix Scientific Group's Regen BioPharma Submits Response to FDA
Questions Regarding HemaXellerate Clinical Program
8:30 a.m. June 7, 2013
- Marketwire